Overview |
bsm-90118R |
ERK1 Recombinant Antbody Kit (KD-Validated) |
WB, FCM |
Knockdown Validated |
Human, Mouse, Rat |
Specifications |
Unconjugated |
Rabbit |
A synthesized peptide derived from human ERK1 |
50-100/379 |
Monoclonal |
IgG |
Lot dependent |
Affinity Purified |
0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
-20 °C |
Target |
5595 |
P27361 |
MAPK3; Mitogen-Activated Protein Kinase 3; ERK1; PRKM3; Extracellular Signal-Regulated Kinase 1; Microtubule-Associated Protein 2 Kinase; Insulin-Stimulated MAP2 Kinase; EC 2.7.11.24; P44-ERK1; P44-MAPK; P44ERK1; P44MAPK; ERK-1; ERT2; Extracellular Signal-Related Kinase 1; MAP Kinase Isoform P44; MAP Kinase 3; EC 2.7.11; HS44KDAP; HUMKER1A; P44mapk; P44erk1; MAPK 1; MAPK |
Cell Line: HeLa Knockdown technology: shRNA Knockdown |
Application Dilution |
WB |
1:300-5000 |
FCM |
1:20-100 |